ArticleCancer research and treatment2020

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

Kyoungmin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.